ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000132.1|Pyrrolomycin_1 # 1 # 1752 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.674	BGC0000132.1|Pyrrolomycin_1 	1	1752	+	Loose	600	40.0466	Streptomyces venezuelae rox	23.35	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGCCCAGGAGCACGAGGCCCACCAAGCCGACAATGAACAAGAAGCCCGACACCGATGTGGTGATCCTGGGTTCCGGGCTCGCCGGGGCGGCGCTGGCGGCGGTGCTCTCCCGCAACGGCGCCAATGTCCTGGTGCTCGACGCCGGAACGCACCCGAGGTTCGCGATCGGGGAATCCACCATCCCCTACACCTCGATGCTGATGCGCCTGGTCAGCGAGCGCTACGACGTTCCCGAGATCAAGTACCTGACGACTTTCGAGAACGTCCAGGGGAAAATCGCCACCACCTCCGGGATCAAGAAGAACTTCGGCTTCCTCTACCACCGCGAGGGCGACCGCCAGAAGTACCACGAGGCCCACCAGTTCCCGATCCCGCGCATCACCCACATCGAGAACCACTTCTTCCGCCAGGACATCGACGCCTGGATGCTGAACGTGGCGGTCAAGTACGGGGCGCGCGTCCAGCAGCGCACCAAGATCGTGGACGTGTCCTTCGACGACGCCGGCGGCACCCTGACCGACGACCGCGGCAACACCTACCGCACCCGCTTCGTCGTGGACGCCAGCGGCTTCCGCTCCCCCATCGCCGAGAAGCTGGGCCTGCGCGACACACCCACGCGCATGCGCCACCACTCGCGCTCCCTGTTCACCCACATGGTGGGCGTCGCCAACTACGACGACCTGCTGCCGAAGGTCTCCCACGGCCACCCCACCCCGTGGTACCAGGGCACCCTGCACCACCTCTACGAGGGCGGCTGGGCCTGGGTCATCCCGTTCAACAACCACGCCCGCACCACCAACCCCCTGGTCAGCGTGGGCATCAACCTCGACCCGCGGATCCACCCCGACTTCGACGGCACCCCCGAGGAAGAATTCCGCGCCTTCATCGCGCGCTTCCCCGACATCCGCCGCCAGTTCGTGAACGCCACCGCCGTGCGGCCGTGGGTGCGCACCGGGCGCCTGCAGTACTCCTCCAGCAAGACCGTGGGCGCGCGCTGGTGCCTGACCTCCCACGCCTCCGGATTCGTGGACGCGCTGTTCTCCCGCGGCCTGTCGAACTCCTTCGAGATCATCAACGCGCTCACCTGGCGGCTGCTGGAGGCGCTCAAGGACGACGACTTCACCGAGGAGCGCTTCGAGTACGTGCAGCGCCTGGAGCAGGGCCTGCTGGACTTCAACGACAACCTCGTGGCCAACGCCTACACCAGCTTCGGCGACTACGACCTGTGGGACACCTGGTTCCGCGTGTGGTCGCTCGGCCAGATCCTGGCCACCTTCGAGATCAACAGCGCCTACGCCAAGTTCCTGGGCTCGCACGACGTGCGGGACCTGGCCCGGCTGGAGAGCATCGCCCCCGACGGCTCCATCCCCGCCTACGCACCCGCGCGCGAGCTGATGACCTTCGTCAGCGACCGGGTCCGCGAGGTGCAGGACAAGCGGGCGGACCCGAAGGTCGCCGCCAAGGAGATCATGGCCGCGCTCGTCAAGGCGGACTTCGTCCCGCCCGCGTTCGGGCTCGCCGACCCCGACAACCGCTGGTTCAACGCCAGCCCCCTCAAGGTCGCCGAGACCATCCGCTGGTCCCGCAACCAGGCGCCCAAGGACATCGGCGCCATCGTCGACGAGGGCCTGACGCTGTTCATCAAGAAGCGCCTGTCCCCCGAGGAGTTCAACCTCACCGAGGAACTCAAGCACATCGTCGCCACCTGGCCCGTGATCGGACGCAAGCTCCGCTCCCCCCTCGCCCCCTGA	MPRSTRPTKPTMNKKPDTDVVILGSGLAGAALAAVLSRNGANVLVLDAGTHPRFAIGESTIPYTSMLMRLVSERYDVPEIKYLTTFENVQGKIATTSGIKKNFGFLYHREGDRQKYHEAHQFPIPRITHIENHFFRQDIDAWMLNVAVKYGARVQQRTKIVDVSFDDAGGTLTDDRGNTYRTRFVVDASGFRSPIAEKLGLRDTPTRMRHHSRSLFTHMVGVANYDDLLPKVSHGHPTPWYQGTLHHLYEGGWAWVIPFNNHARTTNPLVSVGINLDPRIHPDFDGTPEEEFRAFIARFPDIRRQFVNATAVRPWVRTGRLQYSSSKTVGARWCLTSHASGFVDALFSRGLSNSFEIINALTWRLLEALKDDDFTEERFEYVQRLEQGLLDFNDNLVANAYTSFGDYDLWDTWFRVWSLGQILATFEINSAYAKFLGSHDVRDLARLESIAPDGSIPAYAPARELMTFVSDRVREVQDKRADPKVAAKEIMAALVKADFVPPAFGLADPDNRWFNASPLKVAETIRWSRNQAPKDIGAIVDEGLTLFIKKRLSPEEFNLTEELKHIVATWPVIGRKLRSPLAP	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	122.48	gnl|BL_ORD_ID|4833|hsp_num:0	5820			6	687	rifampin; rifaximin; rifapentine
BGC0000132.1|Pyrrolomycin_2 # 1787 # 3445 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.678	BGC0000132.1|Pyrrolomycin_2 	1787	3445	+	Loose	550	32.7278	Nocardia farcinica rox	30.91	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGATCTCGAAGGCACAACGCTTCGACGTCGCCATCATCGGCGCCGGCATGGGCGGCTCGATGCTGGGCGCGGCACTGGCCCGCAACGGCGTCAAGGTCCTGCTCATCGACGGCGGGGTGCACCCCCGGTTCGCGGTCGGAGAGGCCACGATCCCGTACACCAACGTCAGCCAGCGCATCATCGCGGCCCGCTACAACCTGCCCGAGCTGACCACGCTGTGCACGCTCGAGGACTGCGCCAAGACCATCGGCCCCACGTTCGGGACCAAGACCCACTTCGGGTTCCTGCGGCACGAGCAGGGCAAGCCGCAGAACCCCCGCGAGACCAACGAGTTCCACACCCCCGGCCTGCTGCACGAGGCGCACCACCTGTACCGGCAGGACGTGGACGCGTTCGTCTTCCACCTGGCCGTGCAGTGCGGGTGCACCCCGCTGCAGAACTGGCGGGTCGCCGACGTGGACTTCGACGGCTCGGGCGCGTCGCTGCACGGCGAGGACGGCTCGGAGTACCGGGCGCGGTACGTGGTGGACGCCAGCGGCTTCCGCTCCCCGCTGGCGCAGAAGTTCAACCTGCGCGACGAGATCCCGGTGTACAAGCACCAGTCCCGCTCCATGTTCACCCACGTGTACGGGATCACCCACACCGACGACCTGTGGCCGGACCGCAAGCCGGAGTACGTGCCGCCGGTGCCGTGGTACGAGGGCACCGTCCACCACACGTTCAACCGGGGCTGGGCGTGGGTGATCGGCTTCGACAACACCCCGCTGTCGCGCAACCCGCTGTGCTCGATCGGCCTGACCGTGGACCCCCGGGTGTGGCCCAAGGACCCGAACCTGTCGGTGCAGGAGGACTTCGACCGGATCACCGGCCTCTACCCCGACATCAGGCGGCAGTACGAGGGCGTCACCCCGGTGCGCGAGTGGGTCTCCACCGACCGCCTCCAGTACTCCTCCAAGCAGACCGTCGGCGACCGCTGGTGCCTGCTGTCGCACGCGGCGGCGTTCATCGACCCGCTGTTCTCCTACGGCCTGGCCAACACCGGCGACGCCGTGAACAAGCTGGCCTGGCGGCTGATCCGGGCGTGCAAGGACGACGACTTCTCGGCCGAGCGCTTCGACCACATCGAGCAGTGGCAGCAGGCCCGCTTCCACTACAACGACGAGATCGTCAACGCCGGGTTCACCGCCTTCGACCACTTCGAGTTCTGGAAGGCGGTCTTCCGGGTCTGGGTGTGGGGCAACAACTACGGCACCTTCCGGGCGCGCGCCGGCCTGACCAAGTTCGAGAAGGACGGCAACGACCACCACTTCCGGGACCTGGAGAAGGGCCAGTACCTCGGGTACGACTGGCCGGACCACGAGGGCTTCAAGCACCTGTTCGACACCATGGTGGCGAACGTGGACTCCTTCCAGGCGGGGAAGATCACCGCTGACGAGGCGTCCGAGGCGCTGTGGGACGAGATCGAGGCGGCCAACTTCTTCCCCAAGCCGTTCGGGTTCCAGAACCGCAGCGTGCACTTCATGAGCCCGAAGCCGCCGGTCATCGCCAAGACCGCGGTCTGGCTGATGCGTCACGGCGACCCCGACGTGCGCAAGATGCTGCTGCGCAGCGGGCGGCAGGCGGTCAAGCTCCGCCTCACCGGCCGGAAGATCTTCTAG	MISKAQRFDVAIIGAGMGGSMLGAALARNGVKVLLIDGGVHPRFAVGEATIPYTNVSQRIIAARYNLPELTTLCTLEDCAKTIGPTFGTKTHFGFLRHEQGKPQNPRETNEFHTPGLLHEAHHLYRQDVDAFVFHLAVQCGCTPLQNWRVADVDFDGSGASLHGEDGSEYRARYVVDASGFRSPLAQKFNLRDEIPVYKHQSRSMFTHVYGITHTDDLWPDRKPEYVPPVPWYEGTVHHTFNRGWAWVIGFDNTPLSRNPLCSIGLTVDPRVWPKDPNLSVQEDFDRITGLYPDIRRQYEGVTPVREWVSTDRLQYSSKQTVGDRWCLLSHAAAFIDPLFSYGLANTGDAVNKLAWRLIRACKDDDFSAERFDHIEQWQQARFHYNDEIVNAGFTAFDHFEFWKAVFRVWVWGNNYGTFRARAGLTKFEKDGNDHHFRDLEKGQYLGYDWPDHEGFKHLFDTMVANVDSFQAGKITADEASEALWDEIEAANFFPKPFGFQNRSVHFMSPKPPVIAKTAVWLMRHGDPDVRKMLLRSGRQAVKLRLTGRKIF	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	116.70	gnl|BL_ORD_ID|4834|hsp_num:0	5821			324	489	rifampin
BGC0000132.1|Pyrrolomycin_4 # 5879 # 7312 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.789	BGC0000132.1|Pyrrolomycin_4 	5879	7312	+	Loose	800	31.187	Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid	31.25	3003778	protein variant model	V246A	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant ndh	ATGAGGGCGCGCCGGGTCGTCATCGTCGGCAACGGGATGGCGGGGCACCGCGTCGCGCAGGCGCTGGTGGCCCGGGGCGACGGGTCGCGGATCACCCTCGTCGGCGAGGAGCCGCGCCCCGCGTACAACAGGGTGCTGCTCTCGTCGGTGCTGGCCGGCCAGGCGGACGCGGACGCCCTGGAGCTGCCCGACCCGGGCGTGCGGGCGTGTCTCGGGGTGCGGGCGACGGCCCTGGACACGGCGGCGCGCCGGGTGGGCCTGTCCGACGGCACCGACCTCCCCTACGACGCGCTGGTCCTCGCCACCGGCGCACGCCCGCTGATACCGCCGGTGCCGGGGCTCTCCCTGCCCGACGGCTCGCCCGCGCCGGGCGTGGCGACGTTCCGGACGCTGGAGGACTGCGCCGGCATCGCCCGGCTGGCGTCGTCCGGGCCCATGGCGGTGCTCGGCGGCGGGCTGCTCGGGGTGGAGGCCGCCCGCGGCCTGGCCGGGCTCGGCGTGGACGTCACACTCGTCCACCCGTTCGGGCACCCGATGGAGAGCCAGCTCGACGCGGAGGCGGGGGCGGTGCTCGCCGGAGTGCTGCGCGGGCTCGGGGTGCGGCTGCTGCTGGGGCAGGGCGCGGCGGAGTGGAAGCCGGGCGCCCCCGCCACCTCCGAAGGACCCGGCGATCCGGGGCGGCTCACGCTGACGGACGGGTCCACGGTGCGCTGCTCCGGGGTCGTGGTGACCGCCGGGGTGGCCCCGGCGGTGGACCTGGCGCGGGCGGCGGGCCTGGCCGTGCGGCGCGGCATCGTCGTGGACGACCGGCTGGCCGCGTCGGCGCCGGGGGTGTACGCGGTCGGGGAGTGCGCCGAGCACCGGGGCGTGTGCCACGGCCTGGTCGGGCCGTGCTGGGAGCAGGCCGACGCGCTCGCCGCCGTGCTCACCGGCTCCGGCGGCGGGTACACCGGCTCGCGCCCGGTGATCCGGCTGAAGGCGCGGGACATCGACCTGGCGGTCATGGGCCGGGTGCCCCGCGAGCCCGACGACGGCACGGAGGTGGTCCGGGTCTCGGACCCGGCGCGGGGCCGCTACGGCGCGCTGGCGCTGCGCGCGGACCGCGTCGTCGGCGCCGTGCTGCTGGGCCTGTCCGAGGCCACGGGGCCGGTGACGCACCTGCACGACGACCGGTCACCGGCGCCCGCCGACCGCTTCTCCCTCCTCCTGGGCCGCACCGGCGGGGCGGTCACCGGGTCCCCGGCCGCCCTGCCGAACCGGGCCCTGGTGTGCCGCTGCAACGGGGTGACCAAGTCCCGCCTCGTGGAGGCGTGGCGGTCGGGCGCCCGCGACCCGGCGGCCCTGGCGAGGACCACGTGGGCGACGACGGGCTGCGGCGGCTGCGCGGACACCGTCACCGAGGTGTGCGCGTGGCTGGAGAGGGAGTCCGCGTGA	MRARRVVIVGNGMAGHRVAQALVARGDGSRITLVGEEPRPAYNRVLLSSVLAGQADADALELPDPGVRACLGVRATALDTAARRVGLSDGTDLPYDALVLATGARPLIPPVPGLSLPDGSPAPGVATFRTLEDCAGIARLASSGPMAVLGGGLLGVEAARGLAGLGVDVTLVHPFGHPMESQLDAEAGAVLAGVLRGLGVRLLLGQGAAEWKPGAPATSEGPGDPGRLTLTDGSTVRCSGVVVTAGVAPAVDLARAAGLAVRRGIVVDDRLAASAPGVYAVGECAEHRGVCHGLVGPCWEQADALAAVLTGSGGGYTGSRPVIRLKARDIDLAVMGRVPREPDDGTEVVRVSDPARGRYGALALRADRVVGAVLLGLSEATGPVTHLHDDRSPAPADRFSLLLGRTGGAVTGSPAALPNRALVCRCNGVTKSRLVEAWRSGARDPAALARTTWATTGCGGCADTVTEVCAWLERESA	MSHPGATASDRHKVVIIGSGFGGLTAAKTLKRADVDVKLIARTTHHLFQPLLYQVATGIISEGEIAPATRVILRKQKNAQVLLCDVTHIDLENKTVDSVLLGHTYSTPYDSLIIAAGAGQSYFGNDHFAEFAPGMKSIDDALELRGRILGAFEQAERSSDPVRRAKLLTFTVVGAGPTGVEMAGQIAELADQTLRGSFRHIDPTEARVILLDAAPAVLPPMGEKLGKKARARLEKMGVEVQLGAMVTDVDRNGITVKDSDGTIRRIESACKVWSAGVSASPLGKDLAEQSGVELDRAGRVKVQPDLTLPGHPNVFVVGDMAAVEGVPGVAQGAIQGGRYAAKIIKREVSGTSPKIRTPFEYFDKGSMATVSRFSAVAKVGPVEFAGFFAWLCWLVLHLVYLVGFKTKIVTLLSWGVTFLSTKRGQLTITEQQAYARTRIEELEEIAAAVQDTEKAAS	104.38	gnl|BL_ORD_ID|4710|hsp_num:0	2287			321	978	isoniazid
BGC0000132.1|Pyrrolomycin_5 # 7655 # 8638 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.750	BGC0000132.1|Pyrrolomycin_5 	7655	8638	-	Loose	600	25.409	OprZ	35.14	3004142	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGCATCGCAGTGACAGGTTCGATCGCGACCGATCATCTGATGGTCTTTCCGGGCAGCTTCACCGAGCAGCTCATCGAGGGCAGCCTGGAGAAGGTCTCGCTGTCCTTCCTCGCCGAATCCCTCGACATGCGCCACGGCGGGGTCGCCGCCAACGTCTGCTTCGGCCTGGGCGGCCTCGGCCTGCGGCCGCTGCTGGTCGGGGCCGTGGGCCGCGACTTCGAGGACTACCGCGTCCGGCTGGAGGAGCACGGCGTGGACACCTCCGCCGTACACGTCCACGACACCCGGCACACCGCGCGCTTCGTGTGCACCACCGACCGCGACCTCAACCAGATCGCGACCTTCTACGCCGGGGCCATGGCCGAGGCCCACCGGATCTCCGTGGCGCGGGCCGCGGCGCGCGCCGGGGGCGTGGACCTCGTGCTGGTCTCGCCCGACGACCCGGCGGCGATGCTGCGCCACACCGCGGAGTGCCGCGCGAACGGGCTGCCGTTCGCCGCCGACCCCTCGCAGCAGCTCGCCACGCTGGGCCGGGACGAGGTGCGGGAGCTGCTGGACGGGGCGCGCCACCTGTTCACCAACGAGTACGAGGCCGCGCTGCTCCAGGAGCGCGCCGAGTGGACGGCCGAGCAGGTGCTCGCGAGGGTCGGCTGCTGGGTGACCACGCTCGGCGCCGAGGGGGCGCGGGTGGAGACCGCGTCCGGCGACACCGTCAAGGTGCCCGCCGTGCCGGTGGCCGGCACGGCCGACCCGACGGGCGCGGGGGACGCCTTCCGCGCCGGGTTCCTGGCCGGTCTGGCCTGGGACCTGGGCCCGGAGCAGGCGGCCCGGCTCGGCTGCGCGCTGGCCGCGTCCGTGCTGGAGGTGGTGGGCACGCAGACGTACCGGCTGAGCGGCGCGTCCCTGCTGGAGCGGATCCGCGCCGGGTACGGGGACGCGGCGGCCGGGCAGTTCGCGCCCCGGCTCGCGGCGGTGGGCTGA	MRIAVTGSIATDHLMVFPGSFTEQLIEGSLEKVSLSFLAESLDMRHGGVAANVCFGLGGLGLRPLLVGAVGRDFEDYRVRLEEHGVDTSAVHVHDTRHTARFVCTTDRDLNQIATFYAGAMAEAHRISVARAAARAGGVDLVLVSPDDPAAMLRHTAECRANGLPFAADPSQQLATLGRDEVRELLDGARHLFTNEYEAALLQERAEWTAEQVLARVGCWVTTLGAEGARVETASGDTVKVPAVPVAGTADPTGAGDAFRAGFLAGLAWDLGPEQAARLGCALAASVLEVVGTQTYRLSGASLLERIRAGYGDAAAGQFAPRLAAVG	MKPVAMTLLALALSGCSLAPTHERPAAPVPAQYDTPAQPGQAAAPQDWRAYFNDPALQAWIAAALANNRDLRVAALRIEEARALYGVQQSERLPAIDASGEFSRGRATEPGQPRTPVSNRYRAAVGITAFELDFFGRVRSLSDAALARYLASEEAHRAATLALVAETATAYFNQRSLAEQLRLTDDTLALRETTLKLTQRRYDAGLETAIGLRTAQMLVESSRATRAELTREASLARHALGLLAGDFALPLGVDPTPLESQSLTPLAAGLPSELLTRRPDLRQAEQALRAANADIGAARAAFFPSVQLTTDIGTTADRFSDLFSGGTGGWSFAPRLTLPIFNAGRNRANLSLAETRKHIAVAQYEGSIQAAFRDVADALSARDALRDQIEAQRKVRDADRERQRLAERRYARGVANYLEMLEAQRSLFESEQEFIRLQQRRLVNAVDLYKALGGWDDGSSPAS	70.63	gnl|BL_ORD_ID|2408|hsp_num:0	2796			1254	1365	erythromycin; cefepime
BGC0000132.1|Pyrrolomycin_6 # 9062 # 9508 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.680	BGC0000132.1|Pyrrolomycin_6 	9062	9508	-	Loose	450	25.7942	rmtD	34.88	3002667	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGAGCGAAACTCCATCCACGTTCTCCGGATACTACAAATCGACCTATCAGGGAAAAACCGCTTTGACGGCTCGTCCGCCCTGGGACATCGGTGAGCCGCAGACCCCGTTCGTGGAAATACAGAAGGCGGGGCTGATCAAGGGGGAGGTGCTGGACGCCGGCTGCGGCAACGGCGAGATCTCCCTGTTCCTCGCCGCCGAGGGGCACCACGTCACGGGGATCGACATCGCCGAGGGAGCCATCGCGAGGCGCACGGCGGGCGGAGGAGCGGAAGCTCTCGCGACGTTCGCGGTCCGTCGCGCGCTCGACCTGTCGGCGTACGAGAGCCGCTTCGAGACGGTCGTCGACTGCGGCTGTTCCACGCCCTGCCCACGGAGGCGCAGGCGCTACGCGGCCGAGCTGCACCGCGCGACGTCGCCGGGGCCCGTGCCTACCTGCTCGAGATGA	MSETPSTFSGYYKSTYQGKTALTARPPWDIGEPQTPFVEIQKAGLIKGEVLDAGCGNGEISLFLAAEGHHVTGIDIAEGAIARRTAGGGAEALATFAVRRALDLSAYESRFETVVDCGCSTPCPRRRRRYAAELHRATSPGPVPTCSR	MSELKEKLLASKKYRDVCPDTIERIWRECSAKFKKEKDVDKAAREALHGVTGAFMTEREYKRAMEMAAARDWEALLGMHASTRERLPVESMDRVFDQLFEASGTPARILDLACGLNPVYLAHRLPNAAITGVDISGQCVNVIRAFGGAEARLGDLLCEIPEDEANAALLFKVLPLLERQRAGAAMDALMRVNAEWIVASFPTRSLGGRNVGMEKHYSEWMEAHVPENRAIAARLTGENELFYVLKRK	59.92	gnl|BL_ORD_ID|1702|hsp_num:0	1843			321	450	amikacin; tobramycin; arbekacin; gentamicin A; gentamicin
BGC0000132.1|Pyrrolomycin_7 # 9791 # 11008 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.710	BGC0000132.1|Pyrrolomycin_7 	9791	11008	+	Loose	600	29.6462	clbC	24.76	3002816	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGAACGAGAAAGCCACTCCCTTCCCTTTCCCGGATTCCGGGCTCCTGGAATTCCCGCAGCAGTGGGCTGAATTACGCGGCGAATGCCCGGTGGCCAGGGTGGAGTTACCCCACGGCGCCCACGCGTGGCTGGCCACCGGCTACGACGAGGTGCGCAAGGTGCTGGTCGACCCCCGGTTCAGCCGGGCCAGGGCGGCCGAGCACGAGAACCGGCGGCTCACCCCCGCCGTCATCCTCAACAGCTCCCTGATCGGGCTCGACCCGCCGGACCACACCCGGCTGCGCAGTCTGGCGAGCCACGCCTTCACCGCCAGGCGCGTGGAGCGCCTGCGCCCCCGGGTCGTCGAGACCATCACCGCGCTGCTCGACTCCTTCGAGCGGCGGGAGAAGCCGGCCGACCTGATGGAGCACGTCCTGTGGCCGCTGCCGGCCACGCTCATCGGCGAGATGATGGGCGTCCACCCCGAGGACAACCAGCGGTTCATCGCCTGGTCCTCGATGGCGCTGGCCGGGCCCGAGCGCCTGGAGACGGCGACCGAGGGGTACGAGAACCTGAAGGCGTTCTTCGGGGAGCTGATCGCCGAAAAGCGCAAGTCCCCCGGGGACGACCTGCTCAGCGCCCTGATCGAGGCGACGGACGAGCAGGGAAGGCTGACCGACGAGGAGCTGGTGGCGCTGAGCGTGCTGCTCCTGGTCGCCGGGCACGAGTCCACCACCACCGTGTTCGGCACGTTCATCGTCGTCCTGACGCAGCAGCGGCCCGAGCAGTGGCAGCACCTGCTCGAGCACCCCGAGGACATCACCCGCACCGTCGAGGAGCTGCTCAGGACCACCCACCGGACCAAGGTCGGGGCGCGTTGCCCGCGCGTCACCACCGAGGACGTGACCCTCGGCGGGGTGCGCATCGCGGCCGGCGAGGCCGTCATCCCCGCCCCGGACGCCGCCAACCGGGACCCCGCGGTCTTCGCCGAGGACCCGGAGCGGATCGACTTCGCGCGCGCCGAGAACCCGCACTTCGCTCTCGGGGCGGGCACCCACTTCTGCATCGGCGCCGCGCTGGCCCGCATGGAGATCCAGGAAGGGCTGCGGCTGATGCTGAACGGCTGCCCGAGGCTGCGGGTGGCCGTTCCCATGGAGGATCTGCGGCTGACCCCGGGGACGCCCATGCGCGTGCTGGAGACGCTTCCCGTCACCTGGTACGTCTCCCGGGCCGCCTAG	MNEKATPFPFPDSGLLEFPQQWAELRGECPVARVELPHGAHAWLATGYDEVRKVLVDPRFSRARAAEHENRRLTPAVILNSSLIGLDPPDHTRLRSLASHAFTARRVERLRPRVVETITALLDSFERREKPADLMEHVLWPLPATLIGEMMGVHPEDNQRFIAWSSMALAGPERLETATEGYENLKAFFGELIAEKRKSPGDDLLSALIEATDEQGRLTDEELVALSVLLLVAGHESTTTVFGTFIVVLTQQRPEQWQHLLEHPEDITRTVEELLRTTHRTKVGARCPRVTTEDVTLGGVRIAAGEAVIPAPDAANRDPAVFAEDPERIDFARAENPHFALGAGTHFCIGAALARMEIQEGLRLMLNGCPRLRVAVPMEDLRLTPGTPMRVLETLPVTWYVSRAA	MKVVNHATKYERLKHFLNALNEPTYRYKQITEAIFKHRIGAFNKMTTLPKALRESLINEFGPSILTVEPVLETTSQQVTKVLLKVAGNNQVEAVRMHYEAGWESFCISSQCGCGLGCTFCSTGAIGLKQNLSADEMTDQLLYFYLKGHSLDSVSFMGMGEALANVRIFDALNVLVDRQLFALSPRRITVSTVGIIPNIQRMTSSFPQMNLTFSLHSPFHDQRSELMPINNKYPLDQVMNVLDQHIHETGRKVYIAYVMLRGVNDSEKHAEALVKRILNNRYPHLYHVNLIRYNPTVGTPENYGQTIEEKLQTFYRVVKSARIPVTIRSQFGREIDAACGQLYGQYQAKKR	115.71	gnl|BL_ORD_ID|1512|hsp_num:0	1642			669	969	lincomycin; clindamycin; azidamfenicol; chloramphenicol; thiamphenicol; virginiamycin M1; tiamulin; madumycin II; griseoviridin; dalfopristin
BGC0000132.1|Pyrrolomycin_8 # 11122 # 11433 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.718	BGC0000132.1|Pyrrolomycin_8 	11122	11433	+	Loose	800	27.7202	MuxA	31.88	3004073	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCGACCGTGCCCCCGGCACCGTCACCCTCGTCAACGTGTACTCGGTCGACCCGGAACGCCAGGGCGAGCTGGTCGACCTGCTCAACCGCACCGCCGAGGAGCTGATGCGCCACCAGCCGGGCTTCATCGCGGCCAGCGTCTACCGCAGCCTGGACGGCACCCGCGTGACCAACCACGCGGAGTGGCGCTCGGTGGCCGACTTCCAGGCCGTGCAGCGGCTGCCGGAGGCCGCCACGTACGTCAAGGCCTCCGCCGAGCTGGGCGCCTCCGACCCGCACGTGTACGAGGTGGCCCGCACGCACACCTGA	MSDRAPGTVTLVNVYSVDPERQGELVDLLNRTAEELMRHQPGFIAASVYRSLDGTRVTNHAEWRSVADFQAVQRLPEAATYVKASAELGASDPHVYEVARTHT	MTPTTGKSKFRTLRPWLITALAFAAVIGLVMWLAAPASAPSSDGRPGRGGKPGAALPKANALTVGVARVEQGDLALHFNALGTVTAFNTVNVKPRVNGELVKVLFQEGQEVKAGDLLAVVDPRTYKAALAQAEGTLMQNQAQLKNAEIDLQRYKGLYAEDSIAKQTLDTQEAQVRQLQGTIRTNQGQVDDARLNLTFTEVRAPISGRLGLRQVDIGNLVTSGDTTPLVVITQVKPISVVFSLPQQQIGTVVEQMNGPGKLTVTALDRNQDKVLAEGTLTTLDNQIDTTTGTVKLKARFENADGKLFPNQFVNVRLLAQTLKGVLTIPANAVQRGTNGIYVYVVGADNKVSQRSVAIGTSENERVVVESGLKAGEQVVVEGTDRLRDGMEVRVAEASPQVLEGEPQKPQTGRPSGLQGDSVGSGSAE	24.18	gnl|BL_ORD_ID|2242|hsp_num:0	2717			237	435	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000132.1|Pyrrolomycin_9 # 11584 # 12264 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700	BGC0000132.1|Pyrrolomycin_9 	11584	12264	-	Loose	400	26.5646	Erm(31)	26.19	3000598	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGATCTTTTTTATGGATCACACCAAGTTATTCTTCCAGGACGTCTACGGGAGCGCCTCGAACTTCGGGCAGGCGAGGCCTCCGTGGGACATCGGAGAAGCCCAGCCCGCTTTCGTCGAGCTGACAGAGGCCGGGGCGGTCAAGGGTGAGGTGCTGGACGCGGGGTCGGGCCCCGGATGGGTGAGCCTGTTCATCGCCTCGCAGGGACACGCGGTCACCGGTATCGACCTGTCGGCGGACGCCGTCGAGGCGGCCAACGCCAAGGCCGCGGACAGCGGCGTGAACGCCACGTTCGCCGTGGGCGACCTGCTGGACCTGTCGGAGTACCGGGGGCGTTTCGACACGGTCGTGGAGTGCGGCGTCTGCCACGGTCTGGGCGCGGACCCAGGCCCGCAGTACGCCCGCTCCCTGTACGGCGCCACGAAGCTGGGCGCCGTGGCCCACCTGCTCAACCTGAGCGTCGAGGGCTACGAGACCGCCGGGGTCAGGTGCGCCGAGCTGGGCGTGCCCCCGCAGGCGCTCGCCGGGTTCCACGCGGTCACGCCCGAGGACCTGCGCGCCGCCTTCGCCGAGGGCTGGTCCGAGGTCTCCATCACGGAGTCGCGGATGAAGCTGCGCTTCCCGGGCGACACCGGACCCGTCGAGCTGTCCGCCTGGCTCAGCACCTTCCGGCACGACTGA	MIFFMDHTKLFFQDVYGSASNFGQARPPWDIGEAQPAFVELTEAGAVKGEVLDAGSGPGWVSLFIASQGHAVTGIDLSADAVEAANAKAADSGVNATFAVGDLLDLSEYRGRFDTVVECGVCHGLGADPGPQYARSLYGATKLGAVAHLLNLSVEGYETAGVRCAELGVPPQALAGFHAVTPEDLRAAFAEGWSEVSITESRMKLRFPGDTGPVELSAWLSTFRHD	MAFSPQGGRHELGQNFLVDRSVIDEIDGLVARTKGPILEIGPGDGALTLPLSRHGRPITAVELDGRRAQRLGARTPGHVTVVHHDFLQYPLPRNPHVVVGNVPFHLTTAIMRRLLDAQHWHTAVLLVQWEVARRRAGVGGSTLLTAGWAPWYEFDLHSRVPARAFRPMPGVDGGVLAIRRRSAPLVGQVKTYQDFVRQVFTGKGNGLKEILRRTGRISQRDLATWLRRNEISPHALPKDLKPGQWASLWELTGGTADGSFDGTAGGGAAGSHGAARVGAGHPGGRVSASRRGVPQARRGRGHAVRSSTGTEPRWGRGRAESA	70.19	gnl|BL_ORD_ID|1068|hsp_num:0	1156			96	222	narbomycin; methymycin; pikromycin
BGC0000132.1|Pyrrolomycin_11 # 13704 # 19907 # -1 # ID=1_11;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.753	BGC0000132.1|Pyrrolomycin_11 	13704	19907	-	Loose	400	29.261	AAC(3)-IVa	33.9	3002539	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGGACGCCTACCAGCTCGTCGGCGAGCCCAGCTTCGCGGCCGGGCGGATCTCCTACACCCTGGGCCTCCAGGGCCCCAGCAAGGTCATGGACACCACGTGCTCCTCGTCCCTGGTGGCGCTGCACGAGGCGTGCCAGGGCCTGCGGCTGCGCGAGTGCGACATGGCGCTGGCCGGCGGGGTGAACCTGATGCTGTCGCCGTACGGCTTCGTGATGATGAGCAAGTTCGCGGGGCTCTCGCCCGAGGGCCGCTGCAAGACGTTCGACGCGAGCGCCGACGGCTACGCGCGCGGCGAGGGCGCGGGCGTGGTGGTGCTCAAGCGCTATTCCGACGCGCTGCGCGACGGGGACAACGTGATCGCCCTGGTCCGCGGCACGGCCGTCAACCACGACGGGCGCAGCAGCGGTCTTACGGTGCCCAACCCGGCCGCCCAGCAGAGCGTCATCCGCGCGGCCCTGAAGCAGGCCGGGATCGCCCCCGGGGACGTGGACTACGTGGAGGCGCACGGCACCGGCACGGCGCTGGGCGACCCGATCGAGCTGCGCGCGCTGGAGGCGGTGATCGGCAGGAACCGGCCGCAGGGCGCTCCGCTGCTGGTCGGCTCGGTGAAGACGAACATCGGCCACCTGGAGTCGGCCGCTGGCGTCGCCGGGCTGCTCAAGCTGGTGCTCGCGCTCCAGCACGGGGAGATCCCGCCGCACCTGCACTTCAACGACCCCAACCCGAACGTGGACTGGAGCCGGCTGCACATCGAGGTCACCGCGGGTGGCCGCGCCTGGCCGGACGCGGGCGGCCGCCCCAGGATCGGCGCGGTGAGCAGCTTCGGCGCCAGCGGCACCAACGCGCACGCCGTGGTCAGCGCGCCCCCGCCCGTCCCCGAGCACGCCCCGGCCCCGGAGCGCGCCGCCCCCGCGGACTCCCACGGCGTGCTGACGCTGTCCGCCAACAGCGAGGAGGCGCTGACCGAGCTGGCCCGCAAGTACGCCCTGCACCTGCGGCGCGAACCGGGCCTGACCGTGGCCGACGCCACCTGGACCACCCAGGTCGGCCGGTCCAGGCAGACCTTCGGCCTCGCCGTGGCCGGCGACTCCCTCGACGCCCTCGCGGACGCCCTGGACGCGCACGCCCGCGGCGAGCGGGACCCGCGCCTGGCCGGGGCGAAGCTGCCGGTGCACAAGTACCGCAAGACGGCCTGGCTGTTCACCGGGCAGGGCGCCCAGTACGCGGGGATGGCCGCCGGGCTCGCCGACGAGCCCGCGTTCCGCGAGGCGTTCGACGCCTGCGCCGCTCTGTTCGACCCGCTGCTGGACCGCCCGCTGGCGTCCGTGGTCTGGCCGGGGCCGGGCGAGGACTCCCCGATCGACGACACGCGCTATACCCAGCCGGCCCTCTTCGCCGTGGAGTACGCGCTGGCCAGGATGTGGCAGGCCTGGTGCCTGAAGCCGAGCGCGCTGCTCGGGCACAGCATCGGCGAGATCGCCGCCGCCTGCGTGGCCGGGGTGTTCACCCTCGAGGACGCGGTCCGGCTGGTCGCCGCCCGCGCCTCGCTGATGGCCGCCCTGCCCCCGGGCGGCGCCATGGCCGCCGTGCACTGCGACGAGGCCACCGCGCGCGCCGCGGTCGCCGCGTACCCCGACACGGTGTCGCTGGCCGCCGTCAACGGCCCGCACACCTGCACCGTCTCCGGCGCGGAGGCGGACGTGGAGGCCGTCACCGCAGCCCTGAAGGAGCAGGGCGTGCGCAGCCAGCGCCTCACCGTCTCGCACGCGTTCCACTCGCCGCTGCTGCGGCCCATGCTGGACGCGTTCCGCGAGGTCGCGCAGGGCATCTCCTACTCCGCCCCGGCCGTCCCCCTGTACTCCAACGTCACCGGGAAGCCGTGGACGCAGGCGGAGGTGGGCCCGGAGTACTGGGTGAGCCACGCCGCCGGGGCCGTGCGCTTCCACGACGGCGTCACCGGCTTGTACGCGGACGGTGTGCGCACGTTCCTCGAGGTCGGGCCGCACCCGGTGCTGACGGGCCTGGGCAGCAGGGCCGTGGAGGACCCCGACTGCGTGTGGCTGCCCTCGCTGCGCCGCCCCGCCCGCAGGGGTACCTCGCTCGACGACCGCACCAGCGTCCGGCAGGCCCTGGGCGTGCTGTACCTGCGCGGCGCCGCCGTGGACTGGAAGACCGTGCACGGCGGCGCCGGGCGGCGCCGGGTCCCGCTGCCCACGGCCGTGTGGCGGGGCGAGTCGTACTGGTTCCCCGAGCGCCGCGACGACGCCGTGTCGCCGGCCGCGGCGCCGCGCGCCGGTACCGAGGTGCCGTCGGTGGGCCTGCGGCTGCGCAGTGCCCTGCCCACGTACGAGGTCGCGGTGGACGACCCGCGCTGGGAGGCGTACGCCCGCGCGGGCAACGACGGCCGCCACTACCTGCCCGTGGGCGCGCTCGCCGCGATCACCCAGGACGCCGTGACCGACGCCCTGGGCGGGCGCTGGGACTGTGTCGAGGAGTGCGTGATCGACCAGCTCATCCCCAGGGACGGGGTGGGCAGGGTCCTGCAGGTCACGCTGACGCCGAACAGCGACGGCCACGCCGTGTTCGAGTGGCACAGCATCACCCCGGCCGAGGAGGCCGCGGGCGCGCCGTGGACCCGGCACGGGCACGGGCTGCTGCGCCGCCGGGTCAGCGGGCGGCGGCTGTCCCCGGCCCTGCAGCTGCACCGCTACGCGGACGCGGTCTCCTACGAGCCCACCACGCTGTCCTCGGCGCTGGCCGGCGCTCTCACCGGCGCCCCGCGGCGCGGCGGGGGCGTGCTGGTGGCGCTCTCGCCGGAGCGCTCCGACGGCGGCCTGAGCTGGGTGGAGATGGCCGACGCCGCGGTGGCCGCGCTGTCCTGGGACGCCGGGGTGGACACCCAGGAGGTCGGGTTCACCCGTCGCGTGGGCGACCTGGTGTGCGAGGACCCGCGGAGGGTGGCGTACGTGCGGGCCACGGCGCACCGCACCACGGGCACCTCGGGCCAGCTGCGCGAGGTGCTGGGCGCGGTGGAGTTCTTCGCCGAGGACGGCACGCCCATGGGCGGCATCGGCGAGCTGCTGGTGGTCGGCGCCAAGGCCGCGCCGCCGCAGAGCGCCCCGTGGCGGCACCCGGACGAGCTGCTGACCCGGGTGGAGTGGCAGCCCGTGGAGGCCGCGCCGTCCCCGGGGCGGCTGGCCGGCGAGAACTGGCTGCTGCTGCCGGACCGCTCCGGCGTCGCCGAGCGGCTCGCCCGGGAGCTGCGCGAGCGCGGCGCCACCTGCCTGGTGGCCGACCCGTGGGAGGACGGCTCCCGGGCGGACGGGACGGGGCACGGCCCCGGCGCCGCCGCCGTCGCCGCGCTGCTGGAGCGCTGGCGCGACCAGGCCGGGGCCGCCGCGACCGCCGACCGCGTCGTCCTGCTCAGCGGCCTGGACGCGCCCGAGCCCGAGGCCGCCGACGCGGACACCCTGGTGGAGTACCGGGACCGCACCGAGCTGACCCTGGTCGCCGTGGTGCAGGGGCTGCTGGCCCGCGAGGACTGCGGCAGGGCCACGGTCTCCCTGGTCACCCGCGGCACCGTGCCCGCCCCGGCGGAGCAGGCCGTCTCGTCCCCGTTCGGCAACACCCTGTGGGGCCTGGGCCGCGTCGTGGCCCTGGAGCACCCCGAGCACTGGGGCGGCGCCGTGGACCTGGACGGCTCCGGGCCGCTCACCGACGACATCCCGGGCCTGGCCGCCGCCCTGCTCGACGTGCGCGCCGAGGACCAGCAGGCGCTGCGCGGCGGCACCCGGTACGCGGCGCGGCTGATGCCGCACCGCCTCGGCCAGGAGGAGCTGCGGCGCACCCCGCGGGTGCGGCAGGACGGCTCCTACCTGGTGACGGGGGCCTTCGGCGGTATCGGCCAGGTGCTGTCGCGCTGGCTCGCCATCAACGGCGCGGGCAGGCTCGTGCTGCTCGGCCGCACCCCGCTGCCGCCCCGCGCCGACTGGGACCTGCCCACGCTGCCCTCCGGGGTGCGGGAGCGGATCGCCCTGGTGCGGGACCTGGAGGCCACCGGCGCCGCCGTGGAGGTGGTCGCCGCCGACGTCAGCGACGTCGGGCAGATGCTGCCCGTCATGGAGCGGCTGGCCGTGGACGCGCGCCCCCTGGCCGGTGTGGTGCACGCGGCCGGCCTGTCCGTCCCGCAGTTCCTGCGCGACATCACCGTGCCGACGCCCGCCGACTACGACGCGGTGTGGCGGCCCAAGGTCGTCGGCGGGTGGCTGCTGCACCAGCTGACCGAGGGCGCCGACCTGGACTTCTTCCTCGGCTTCTCGTCCATCGCGGCGACCTGGGGCTCGCAGCACCTGTCCAGCTACTCCGCGGCCAACGCGTTCCTGGACGGCCTCGCCGAGTACCGGCAGGGCCAGGGCCAGGCCGCGCTCACCGTGAGCTGGGGCCCCTGGGAGCTGGAGTCCAACCTCTTCGGCGAGGACGTGCTGGCGTTCCTGATGTCCACGGCGCTGCGCACCCTGTCCGCGCCGCAGTGCCTGAAGCTGCTCGGCGCGCTGCTGGCCGGGCCGCACGCGCAGGCGGTCGTCTGCGCGGCCGACTGGGCCACGTACAAGCCGGTCATGGAGGCACGGATCGAGCGGCCCCTGCTGCGCACGCTGGAGGTGGTGGAGGACTACGGCGACGAGGACCCGGCGCCGGTGCTGGAGGAGCTGGCCCGCGCGGGCGGCCCGCGGGAGCGGGGCCGCAGGCTCGTCGGCTATCTGCGGGACGTGCTGGGCGAGGTGCTGTCGGTGCCCGCGGACGGCATCGAGCCGGCCGCGGACGTGATGTCCCACGGCCTGGACTCGCTGATGGTCATGGAGGTCGTCAAGCGCTGCAAGAAGGACCTGCGGGTCAGCGTGCGCCCCAACCAGCTGTTCGAACGCTCCACCCTGGAGGACTGGGCGGAGCTGCTCGGCTCCGAGCTCGGCGGCGGCGAGGGCGCGGCCGGCGGCGCGGCACCGGCGGACGCGGCCATGACCGACCCGGCGAACATCGCGGGCGACGTCACGCTCGACCCGTCCATCCGGCCGCGGGGCCCGCTGGGGACCGGCTACCAGGACCCGCGGCACGTGCTGCTCACCGGGGCCACCGGCTTCCTCGGCGCGTCCCTCCTGGGCGAGCTGCTGGCGACCACCGGGGCGACCGTGCACTGCCTGGTGCGCTGCCAGGACCCCGCGGAGGGGCTGGCCAGGATCCGGCAGAACTACGAGAAGTACCTGCCGTGGCGCGCCGCCGACGAGGGCCGGATCGCGGTGGTCCCGGGCGACCTGGAGAAGCCGCTGCTCGGCCTGGACGAGGAGGCCTTCGACGCGCTCGCCCACCGGCTGGACGCGATCTACAACAACGGGGCGTGGGTGAACTTCTCGTACACCTACGAGCAGCTGCGCGCGGCCAACCTCTCGGGCTGCGAGGAGATCCTGCGCCTGGCCTGCCGCGGCCCGCTGACGCCGGTGAGCCACGTGTCCACGTACGGCATCTGGGGCCTGCCCGCGGACGGCCGCACGGTGATCAAGGAGACGGACGACATCGCGGGCGCCGGGAAGCTGGTGACCGGTTACGTCCAGACCAAGTGGGCCGCCGAGCGGCTGATGGAGACCGCGCGGGAGCGCGGCATCCCGGTGGACGTGCACCGGCCCGGCCGGGTGCTCGGCGACTCGCGCACCGGTGCCGCGCTGACCACGCACTTCACCACGCGGGTCATCAAGGGCTGCGTCCAGCTCGGCATCGCGCCGGACCTCGACCTGGAGATCGAGATGACCCCGGTGGACTACGTCACGCGGGCCCTGGTGCGCATCTCCCTGGAGCCGCACGCCTTCGGGGAGACCTACCACCTGGTCAACCGGCGCAAGATGACGTTCGAGCGGCTCGTGCGGGCGATCTCGGCACATGGCTGGACGGCCGACGTCGTGCCCGTGGACCAGTGGTGGAAGGCCCTCCAGGACTCCTACGGGGAGCAGGACAACGAGCTGCACCCGGTCATGGGAGTGGTGGAGGAGTTCGTGGTCGGCGGAGAGGAGGCCATCGACTACGACGCCACCAACACCGAACGGGTCCTGGCGGGCACCGGCATCGCCTGCCCGCCGCTGGACGAGGCCCTGCTGGGCACCTACTTCGCGTGGATGGTGGCCAGTGGCTACCTCCCCGCGCCGGAGCGCCGGTCATGA	VDAYQLVGEPSFAAGRISYTLGLQGPSKVMDTTCSSSLVALHEACQGLRLRECDMALAGGVNLMLSPYGFVMMSKFAGLSPEGRCKTFDASADGYARGEGAGVVVLKRYSDALRDGDNVIALVRGTAVNHDGRSSGLTVPNPAAQQSVIRAALKQAGIAPGDVDYVEAHGTGTALGDPIELRALEAVIGRNRPQGAPLLVGSVKTNIGHLESAAGVAGLLKLVLALQHGEIPPHLHFNDPNPNVDWSRLHIEVTAGGRAWPDAGGRPRIGAVSSFGASGTNAHAVVSAPPPVPEHAPAPERAAPADSHGVLTLSANSEEALTELARKYALHLRREPGLTVADATWTTQVGRSRQTFGLAVAGDSLDALADALDAHARGERDPRLAGAKLPVHKYRKTAWLFTGQGAQYAGMAAGLADEPAFREAFDACAALFDPLLDRPLASVVWPGPGEDSPIDDTRYTQPALFAVEYALARMWQAWCLKPSALLGHSIGEIAAACVAGVFTLEDAVRLVAARASLMAALPPGGAMAAVHCDEATARAAVAAYPDTVSLAAVNGPHTCTVSGAEADVEAVTAALKEQGVRSQRLTVSHAFHSPLLRPMLDAFREVAQGISYSAPAVPLYSNVTGKPWTQAEVGPEYWVSHAAGAVRFHDGVTGLYADGVRTFLEVGPHPVLTGLGSRAVEDPDCVWLPSLRRPARRGTSLDDRTSVRQALGVLYLRGAAVDWKTVHGGAGRRRVPLPTAVWRGESYWFPERRDDAVSPAAAPRAGTEVPSVGLRLRSALPTYEVAVDDPRWEAYARAGNDGRHYLPVGALAAITQDAVTDALGGRWDCVEECVIDQLIPRDGVGRVLQVTLTPNSDGHAVFEWHSITPAEEAAGAPWTRHGHGLLRRRVSGRRLSPALQLHRYADAVSYEPTTLSSALAGALTGAPRRGGGVLVALSPERSDGGLSWVEMADAAVAALSWDAGVDTQEVGFTRRVGDLVCEDPRRVAYVRATAHRTTGTSGQLREVLGAVEFFAEDGTPMGGIGELLVVGAKAAPPQSAPWRHPDELLTRVEWQPVEAAPSPGRLAGENWLLLPDRSGVAERLARELRERGATCLVADPWEDGSRADGTGHGPGAAAVAALLERWRDQAGAAATADRVVLLSGLDAPEPEAADADTLVEYRDRTELTLVAVVQGLLAREDCGRATVSLVTRGTVPAPAEQAVSSPFGNTLWGLGRVVALEHPEHWGGAVDLDGSGPLTDDIPGLAAALLDVRAEDQQALRGGTRYAARLMPHRLGQEELRRTPRVRQDGSYLVTGAFGGIGQVLSRWLAINGAGRLVLLGRTPLPPRADWDLPTLPSGVRERIALVRDLEATGAAVEVVAADVSDVGQMLPVMERLAVDARPLAGVVHAAGLSVPQFLRDITVPTPADYDAVWRPKVVGGWLLHQLTEGADLDFFLGFSSIAATWGSQHLSSYSAANAFLDGLAEYRQGQGQAALTVSWGPWELESNLFGEDVLAFLMSTALRTLSAPQCLKLLGALLAGPHAQAVVCAADWATYKPVMEARIERPLLRTLEVVEDYGDEDPAPVLEELARAGGPRERGRRLVGYLRDVLGEVLSVPADGIEPAADVMSHGLDSLMVMEVVKRCKKDLRVSVRPNQLFERSTLEDWAELLGSELGGGEGAAGGAAPADAAMTDPANIAGDVTLDPSIRPRGPLGTGYQDPRHVLLTGATGFLGASLLGELLATTGATVHCLVRCQDPAEGLARIRQNYEKYLPWRAADEGRIAVVPGDLEKPLLGLDEEAFDALAHRLDAIYNNGAWVNFSYTYEQLRAANLSGCEEILRLACRGPLTPVSHVSTYGIWGLPADGRTVIKETDDIAGAGKLVTGYVQTKWAAERLMETARERGIPVDVHRPGRVLGDSRTGAALTTHFTTRVIKGCVQLGIAPDLDLEIEMTPVDYVTRALVRISLEPHAFGETYHLVNRRKMTFERLVRAISAHGWTADVVPVDQWWKALQDSYGEQDNELHPVMGVVEEFVVGGEEAIDYDATNTERVLAGTGIACPPLDEALLGTYFAWMVASGYLPAPERRS	MQYEWRKAELIGQLLNLGVTPGGVLLVHSSFRSVRPLEDGPLGLIEALRAALGPGGTLVMPSWSGLDDEPFDPATSPVTPDLGVVSDTFWRLPNVKRSAHPFAFAAAGPQAEQIISDPLPLPPHSPASPVARVHELDGQVLLLGVGHDANTTLHLAELMAKVPYGVPRHCTILQDGKLVRVDYLENDHCCERFALADRWLKEKSLQKEGPVGHAFARLIRSRDIVATALGQLGRDPLIFLHPPEAGCEECDAARQSIG	801.16	gnl|BL_ORD_ID|4915|hsp_num:0	639			306	483	dibekacin; sisomicin; apramycin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; 2'-N-ethylnetilmicin; gentamicin
